Cours Mabvax Therapeutics Holdings Inc Other OTC
Actions
US55414P7024
Recherche biotechnologique et médicale
CA 2016 | 148 k 134 k | CA 2017 | - | Capitalisation | 14,41 M 13 M |
---|---|---|---|---|---|
Résultat net 2016 | -17 M -15,33 M | Résultat net 2017 | -19 M -17,14 M | VE / CA 2016 | 147 x |
Dette nette 2016 | 470 k 424 k | Dette nette 2017 | 2,48 M 2,24 M | VE / CA 2017 | - |
PER 2016 |
-0,93
x | PER 2017 |
-0,25
x | Employés | - |
Rendement 2016 * |
-
| Rendement 2017 |
-
| Flottant | 92,02% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/07/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+11,91% | 118 Md | |
+11,60% | 106 Md | |
-4,68% | 24,28 Md | |
-0,82% | 21,96 Md | |
-10,12% | 18,16 Md | |
-42,12% | 16,37 Md | |
-17,47% | 15,56 Md | |
+2,77% | 13,63 Md | |
+34,58% | 12,27 Md |